Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and PrECOG, LLC, will present a variety of abstracts that aim to improve treatments for patients with lymphomas and acute leukemias ...
"Our study shows that adding blinatumomab to consolidation chemotherapy keeps patients in remission and improves their survival. Based on what we found, this approach is the new standard of care for B ...
In the phase III ECOG-ACRIN E1910 study presented at the American Society of Hematology (ASH) annual meeting, consolidation chemotherapy with blinatumomab (Blincyto) improved overall survival in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results